Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts that cover Agios Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $35.63, which forecasts a 30.90% increase in the stock price over the next year. The lowest target is $20 and the highest is $62.

Price Target: $35.63 (+30.90%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$20	$35.63	$38	$62
Change	-26.52%	+30.90%	+39.60%	+127.77%

Analyst Ratings

The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26
Strong Buy	1	1	1	4	4	4
Buy	4	4	4	2	1	1
Hold	1	1	1	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	9	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Berens Leerink Partners	Leerink Partners	Buy Maintains $34 → $40	Buy	Maintains	$34 → $40	+46.95%	Dec 26, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $48 → $62	Strong Buy	Maintains	$48 → $62	+127.77%	Dec 24, 2025
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $32 → $38	Strong Buy	Maintains	$32 → $38	+39.60%	Dec 24, 2025
Greg Harrison B of A Securities	B of A Securities	Strong Buy Maintains $32 → $34	Strong Buy	Maintains	$32 → $34	+24.91%	Dec 24, 2025
Samantha Semenkow Citigroup	Citigroup	Strong Buy Initiates $38	Strong Buy	Initiates	$38	+39.60%	Nov 26, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

46.99M

Increased by 28.75%

from 36.50M

Revenue Next Year

112.52M

Increased by 139.45%

from 46.99M

EPS This Year

-7.20

from 11.64

EPS Next Year

-6.89

from -7.20

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	14.24M	26.82M	36.50M	46.99M	112.52M
Revenue Growth	-	-	-	88.36%	36.07%	28.75%	139.45%
EPS	-4.74	26.55	-4.23	-6.33	11.64	-7.20	-6.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	49.9M	200.6M
Avg	47.0M	112.5M
Low	42.1M	65.7M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	36.7%	326.8%
Avg	28.7%	139.5%
Low	15.5%	39.7%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-5.86	-5.06
Avg	-7.20	-6.89
Low	-7.21	-8.20

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.